Table of Content




1. Executive Summary


2. Global Toxoid Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Toxoid Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Toxoid Vaccine Market by Vaccine Type
3.3.1: Diphtheria, Tetanus, and Pertussis (DTaP)
3.3.2: Diphtheria and Tetanus (DT)
3.3.3: Tetanus, Diphtheria, and Pertussis (TDaP)
3.3.4: Others


3.4: Global Toxoid Vaccine Market by End Use
3.4.1: Hospitals
3.4.2: Specialty Centre
3.4.3: Governments Organization
3.4.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Toxoid Vaccine Market by Region
4.2: North American Toxoid Vaccine Market
4.2.2: North American Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others


4.3: European Toxoid Vaccine Market
4.3.1: European Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.3.2: European Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others


4.4: APAC Toxoid Vaccine Market
4.4.1: APAC Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.4.2: APAC Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others


4.5: ROW Toxoid Vaccine Market
4.5.1: ROW Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.5.2: ROW Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Toxoid Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Toxoid Vaccine Market by End Use

6.1.3: Growth Opportunities for the Global Toxoid Vaccine Market by Region

6.2: Emerging Trends in the Global Toxoid Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Toxoid Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Toxoid Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Bharat Biotech
7.2: Ceva
7.3: GlaxoSmithKline
7.4: Grifols
7.5: Zoetis
7.6: Sanofi
7.7: Merck & Co
7.8: Emergent BioSolutions
7.9: Integrated BioTherapeutics
7.10: Abbott